|
|
------------------------------------------------------------------------Contents (.PDF) Federal RegisterContents (.TXT) Vol. 64, No.53Friday, March 19, 1999------------------------------------------------------------------------RULESNADA 141-061, CVM98165. Implantation or Injectable Dosage Form New Animal Drugs; Doramectin. Pages 13508-13509 [FR Doc. 99-6670] [TXT] [PDF] Freedom of Information SummaryANADA 200-241, CVM98112. Oral Dosage Form New Animal Drugs; Lincomycin HydrochlorideSoluble Powder. Page 13508 [FR Doc. 99-6671] [TXT] [PDF] Freedom of Information SummaryNADA 141-070, CVM98127. Implantation or Injectable Dosage Form New Animal Drugs; Propofol Injection. Pages 13509-13510 [FR Doc. 99-6668] [TXT] [PDF] Freedom of Information SummaryDocket No. 97F-0213, CFSAN9833. Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers. Pages 13506-13508 [FR Doc. 99-6667] [TXT] [PDF] NOTICESDocket No. 99F-0461, CFSAN995. Ticona; Filing of Food Additive Petition. Pages 13586-13587 [FR Doc. 99-6750] [TXT] [PDF] Docket No. 99D-0297, CDER98157. Draft Guidance for Industry on Formal Dispute Resolution; Appeals Above the Division Level; Availability. Pages 13587-13589 [FR Doc. 99-6749] [TXT] [PDF] Written comments on draft guidance by May 18, 1999. Written comments on information collection provisions by April 19, 1999. GuidanceDocket No. 98D-0697, CDRH9915. Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #1; Availability. Pages 13590-13591[FR Doc. 99-6666] [TXT] [PDF] GuidanceDocket No. 99D-0302, CDRH9916. Draft Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #2; Availability. Pages 13589-13590 [FR Doc. 99-6665] [TXT] [PDF] Written comments by June 17, 1999 GuidanceDocket No. 99D-0296, CDER98178. Draft Guidance for Industry on Formal Meetings with Sponsors and Applicants for PDUFA Products; Availability. Pages 13591-13594 [FR Doc. 99-6748] [TXT] [PDF] Written comments on draft guidance by May 18, 1999 Guidance |